Co-Authors
This is a "connection" page, showing publications co-authored by Kirsten Littlefield and Oliver Laeyendecker.
Connection Strength
0.696
-
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers. J Clin Microbiol. 2021 01 21; 59(2).
Score: 0.231
-
A Hemagglutination-Based Semiquantitative Test for Point-of-Care Determination of SARS-CoV-2 Antibody Levels. J Clin Microbiol. 2021 11 18; 59(12):e0118621.
Score: 0.060
-
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. mBio. 2021 04 20; 12(2).
Score: 0.059
-
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. J Clin Invest. 2021 04 01; 131(7).
Score: 0.059
-
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. J Clin Invest. 2021 03 01; 131(5).
Score: 0.058
-
ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population. Vox Sang. 2021 Aug; 116(7):766-773.
Score: 0.058
-
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa574.
Score: 0.057
-
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors. J Infect Dis. 2020 11 13; 222(12):1974-1984.
Score: 0.057
-
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020 11 02; 130(11):6141-6150.
Score: 0.057